﻿<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF xmlns:admin="http://webns.net/mvcb/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://purl.org/rss/1.0/modules/prism/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/">
<channel rdf:about="http://medrxiv.org">
<admin:errorReportsTo rdf:resource="mailto:medrxiv@cshlpress.edu"/>
<title>medrxiv Subject Collection: Pain Medicine Palliative Medicine</title>
<link>http://medrxiv.org</link>
<description>
This feed contains articles for medRxiv Subject Collection "Pain Medicine Palliative Medicine"
</description>

<items>
<rdf:Seq>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.18.26368406v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367897v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.11.26367874v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.11.26367487v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367794v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.06.26367446v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.04.26367278v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.02.26367127v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.27.26364954v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.23.26366298v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.25.26365740v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.21.26366160v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.20.26366046v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.20.26366024v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.20.26365979v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.16.26365778v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.13.26365452v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.10.26365209v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.08.26365039v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.07.26364942v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.02.26364550v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.28.26364170v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.28.26364225v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.29.26364287v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.24.26363855v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.23.26363767v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.1101/2025.10.28.25336335v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.22.26358710v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.24.26358500v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.31.26359372v1?rss=1"/>
</rdf:Seq>
</items>
<prism:eIssn/>
<prism:publicationName>medrxiv</prism:publicationName>
<prism:issn/>

<image rdf:resource=""/>
</channel>
<image rdf:about="">
<title>medrxiv</title>
<url>https://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png</url>
<link>http://medrxiv.org</link>
</image>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.18.26368406v1?rss=1">
<title>
<![CDATA[
Can far become near? The effect of approaching visual stimuli on tactile processing in fibromyalgia patients and controls 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.18.26368406v1?rss=1
</link>
<description><![CDATA[
Within the space closely surrounding us (i.e. the peripersonal space), stimuli on the body surface are integrated with stimuli in the external world. This enables us to interact with the world, and to defend ourselves against potentially threatening objects approaching our body. It has been shown that attention towards stimuli approaching us can differ depending on, for example, the level of anxiety. The present study investigated whether fibromyalgia (FM) patients have a heightened attention to stimuli entering the peripersonal space compared to healthy control participants. This was done by investigating the differential influence of dynamical visual stimuli approaching the body on tactile processing for control participants versus FM patients. For control participants we found, in accordance with previous research, that visual stimuli presented near as opposed to far from the body influenced tactile processing more. For FM patients this difference was less clear, possibly indicating that FM patients have more attention for potentially threatening stimuli at further distance. The curves describing the reaction times along the continuous spatial range (from near to far) indicated that FM patients have a heightened attention for stimuli entering the peripersonal space compared to controls. However, as this difference was only found when curve-fitting the data, we argue that our results should be interpreted with caution and need further corroboration and replication.
]]></description>
<dc:creator><![CDATA[ De Paepe, A. L., Crombez, G., Legrain, V. ]]></dc:creator>
<dc:date>2026-11-20</dc:date>
<dc:identifier>doi:10.64898/2026.11.18.26368406</dc:identifier>
<dc:title><![CDATA[Can far become near? The effect of approaching visual stimuli on tactile processing in fibromyalgia patients and controls]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367897v1?rss=1">
<title>
<![CDATA[
Pain-indicated buprenorphine prescribing in the United States, 2017-2025: national trends, state policy approaches, and payer patterns in a longitudinal ecological study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367897v1?rss=1
</link>
<description><![CDATA[
BackgroundBuprenorphine offers an analgesic option for selected adults with chronic pain. National trends in pain-indicated buprenorphine prescribing, variation across state policy approaches, and consistency within multiple insurance payers have not been examined together. We described national and state prescribing trends, compared growth among states with documented policies, and examined whether state patterns persisted among Medicaid recipients.

MethodsLongitudinal ecological analysis of 2017-2025 prescription claims for 867,591 unique adults receiving transdermal or buccal buprenorphine across 888 three-digit ZIP code areas, with a systematic policy review of the 50 states and District of Columbia. Outcomes were annual recipients of pain-indicated formulations per 100,000 adults, observed and modeled with a hierarchical Bayesian model (95% credible intervals), state policy characteristics, and payer-restricted rates.

ResultsThe observed national rate increased from 53.59 to 78.04 recipients per 100,000 adults (45.6%; 4.81% annualized); model-derived average annual growth was 5.04% (95% credible interval, 2.88%-7.28%). The policy review identified distinct guidance, coverage, oversight, and educational approaches. Annualized growth was 25.43% in Minnesota, 13.50% in Colorado, 6.29% in North Carolina, 3.35% in Virginia, 2.99% in California, 0.63% in West Virginia, 0.50% in Oregon, and -2.96% in Mississippi.

Identifiable-Medicaid prescribing grew 3.10% annualized nationally versus 4.81% for all payers and increased in Colorado and Minnesota, but declined in Virginia and North Carolina, where plan coding and managed-care transitions limited Medicaid identification.

ConclusionsPrescribing increased nationally but varied substantially across states with different policy approaches, and Medicaid-restricted patterns did not consistently mirror all-payer trends. Policy content, timing, and payer reach warrant evaluation; however, these ecological comparisons do not establish causation.
]]></description>
<dc:creator><![CDATA[ Adams, M. C. B., Kline, D. M., Yong, J. C., McDonnell, C., Hurley, R. W. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367897</dc:identifier>
<dc:title><![CDATA[Pain-indicated buprenorphine prescribing in the United States, 2017-2025: national trends, state policy approaches, and payer patterns in a longitudinal ecological study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.11.26367874v1?rss=1">
<title>
<![CDATA[
Exploring perceptions and attitudes toward pain in surgical trauma patients in a public hospital in Guatemala: a qualitative study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.11.26367874v1?rss=1
</link>
<description><![CDATA[
Pain is nearly universal following traumatic injuries. However, pain perception, expression, and coping may be shaped by biological, psychological, social, and cultural factors that remain poorly characterized among underrepresented populations. This study explored experiences, attitudes, and expectations toward pain among hospitalized trauma patients at a public hospital in Guatemala.

We conducted a qualitative study using semi-structured interviews with consenting adults admitted to the orthopedic trauma service at Hospital Nacional de Coatepeque in southwestern Guatemala from May to June 2025. Interviews explored pain experiences, coping strategies, interactions with healthcare providers, and expectations for pain management. Interviews were conducted in Spanish, audio-recorded, transcribed verbatim, translated into English by bilingual researchers, and analyzed using inductive thematic analysis.

Five interrelated themes were identified: 1) lived experience and trajectory of pain; 2) coping, adaptation, and psychological endurance; 3) spirituality, meaning-making, and moral framing of suffering; 4) pain management and interactions with the healthcare system; and 5) social context, responsibilities, and life disruptions. Participants described severe early pain accompanied by physical, emotional, and functional distress that generally improved over time. Psychological coping, faith, and family responsibilities were central to resilience and recovery. Notably, patients often reported acceptable or improving numerical pain scores despite narratives describing substantial physical, emotional, and functional suffering, suggesting that standardized pain scales may not fully capture lived experiences.

Trauma patients in Guatemala described pain as a multidimensional experience shaped by physical, psychological, spiritual, and sociocultural factors. Despite severe pain, patients demonstrated resilience, often accepting pain as a temporary part of healing while prioritizing recovery and return to family responsibilities. The discordance between numerical pain scores and narratives of suffering underscores limitations of pain scores as standalone measures. These findings support culturally informed, patient-centered strategies that integrate pharmacologic treatment with attention to psychological, spiritual, and social dimensions of recovery.
]]></description>
<dc:creator><![CDATA[ Mahalingam, V., Turner, R., Zacarias, K., Ramirez, S., Simmons, C. G., Gamboa, J. E. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.11.26367874</dc:identifier>
<dc:title><![CDATA[Exploring perceptions and attitudes toward pain in surgical trauma patients in a public hospital in Guatemala: a qualitative study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.11.26367487v1?rss=1">
<title>
<![CDATA[
Data-driven modeling of trigeminal nerve shape reveals pain-associated morphology in trigeminal neuralgia 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.11.26367487v1?rss=1
</link>
<description><![CDATA[
Although the leading theory for the cause of trigeminal neuralgia (TN) is neurovascular compression, compression alone does not fully explain which nerves are painful. Recent work has demonstrated that pain in TN is associated with morphological changes of the trigeminal nerve, which may be a result of specific forms of compression or other disease processes. These changes have so far been quantified by hand-crafted geometric measurements, which can miss higher-order characteristics of the anatomy that are difficult to visualize. In this study, we use a cohort of 479 patients with TN who underwent microvascular decompression and had high-resolution pre-operative MRI scans to determine whether data-driven 3D shape features of the trigeminal nerve capture pain-associated morphology better than predefined metrics. We find that a predictive model using our shape features can distinguish nerves implicated in pain from those without pain in a held-out test cohort with an area under the receiver operating characteristic curve (AUROC) of 0.719, compared with 0.626 for a model using existing hand-crafted measurements (p=0.005). Our study identifies candidate nerve morphology biomarkers of TN pain through data-driven shape analysis and demonstrates that these higher-order features relate better to symptoms of TN than conventional shape metrics.
]]></description>
<dc:creator><![CDATA[ Xie, M. E., Liang, H., Wang, X., Yedavalli, V., Jackson, C., Lim, M., Huang, J., Bettegowda, C., Liu, P., Xu, R. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.11.26367487</dc:identifier>
<dc:title><![CDATA[Data-driven modeling of trigeminal nerve shape reveals pain-associated morphology in trigeminal neuralgia]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367794v1?rss=1">
<title>
<![CDATA[
Knowledge, Attitudes, and Practices of Advance Care Planning in Patients with Neurosurgical Conditions and Their Caregivers 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367794v1?rss=1
</link>
<description><![CDATA[
IntroductionAdvance care planning (ACP) enables quality end-of-life (EOL) care that reflects patients values and preferences. However, ACP remains limited among individuals with neurosurgical conditions - such as stroke, glioma, or metastatic brain tumours - who often experience rapid decline and short prognoses. When ACP discussions occur only after cognitive deterioration or acute events, opportunities for meaningful conversations are lost. This study aims to assess the baseline knowledge, attitudes, and practices (KAP) of ACP among neurosurgical patients and their caregivers in Singapore.

MethodsWe conducted a cross-sectional survey of 30 patients with symptomatic intracerebral haemorrhage (SICH) or brain tumours at the National University Hospital and their caregivers. Using validated ACP engagement questionnaires, we assessed participants KAP, and readiness on 5-point Likert scales (1 lowest - 5 best), alongside nine ACP knowledge statements.

ResultsPatients demonstrated below-average ACP knowledge (mean = 4.1 / 9) and largely neutral attitudes (3.2 / 5) and perceptions (3.1 / 5). Misconceptions were common, including beliefs that ACP documents are legally binding, that preferred care cannot be delivered without ACP, and that ACP is solely a doctors responsibility. Consequently, both patients and caregivers showed low levels of ACP engagement.

ConclusionThe findings highlight the need to introduce ACP education and conversations earlier in the care journey, especially for individuals at risk of cerebrovascular or cardiovascular events. Early engagement, particularly among those with hypertension or other risk factors, presents a crucial window for preparing patients and families for future care decisions.

CLINICAL IMPACTO_ST_ABSWhat is NewC_ST_ABSO_LIThis study is the first to assess the knowledge, attitudes, and practices (KAP) of ACP among neurosurgical patients and their caregivers in Singapore.
C_LIO_LIFindings revealed low levels of ACP engagement, below-average knowledge of and prevalent misconceptions regarding ACP among both patients and caregivers.
C_LI

Clinical ImplicationsO_LIThe findings highlight the need to introduce ACP education and conversations earlier in the care journey, especially for individuals at risk of cerebrovascular or cardiovascular events, such as those with hypertension or other risk factors.
C_LI
]]></description>
<dc:creator><![CDATA[ Huynh, V. A., Lim, M. J. R., Ong, S. E., Lim, A., Koh, G. C. H., Foong, P. S. ]]></dc:creator>
<dc:date>2026-11-13</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367794</dc:identifier>
<dc:title><![CDATA[Knowledge, Attitudes, and Practices of Advance Care Planning in Patients with Neurosurgical Conditions and Their Caregivers]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.06.26367446v1?rss=1">
<title>
<![CDATA[
Negotiating the Social Self in Chronic Spinal Pain: A Qualitative Study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.06.26367446v1?rss=1
</link>
<description><![CDATA[
PurposeThis study examined how people living with chronic spinal pain experience, interpret and navigate social representations of their condition and the interactions these generate across clinical, occupational, and personal settings.

Materials and MethodsThirty semi-structured interviews were analysed using an approach informed by constructivist grounded theory, through initial, focused and theoretical coding.

ResultsFive categories emerged, capturing how social representations and relational dynamics threatened the social self and prompted deliberate strategies for restoring agency. Theoretical coding identified a central process (maintaining and rebuilding the social self), describing how participants navigated these threats across social contexts. Notably, approximately half the participants reproduced, without revision, representations of chronic pain typical of the general population, directing judgements of simulation or inadequate effort at others with the condition. These strategies primarily aimed to restore agency and maintain a viable social self, rather than to reduce pain.

ConclusionsThese findings describe one process through which social environments shape the experience of chronic spinal pain by influencing how the social self is continually negotiated. Recognising these processes may help rehabilitation professionals attend to the social dimensions of chronic pain.

Implications for rehabilitationO_LIRehabilitation professionals should recognise that people living with chronic spinal pain often face a substantial and largely invisible burden beyond pain management itself. Continually demonstrating that their pain is real and legitimate can place an additional cognitive and relational burden on patients. Allowing sufficient space in clinical encounters for patients to describe these experiences may help clinicians identify the social difficulties associated with chronic pain and how they affect daily life and participation.
C_LIO_LIShared experience of chronic pain should not be assumed to produce greater empathy toward others in similar situations. Approximately half the participants in this study continued to apply common social representations of chronic pain to other people with the condition. Therapeutic patient education and peer-based programmes should account for this possibility and actively address the representational frameworks participants bring to these settings.
C_LIO_LIRehabilitation assessment should include patients experiences of support, disbelief, paternalism, and changing expectations across healthcare, workplace, and personal settings, as these interactions may shape perceived credibility, control and self-efficacy.
C_LIO_LIClinical training in chronic pain rehabilitation should address both explicit delegitimation and more automatic forms of stereotyping, including how assumptions about what a person in pain should look like or do can influence clinical judgement and communication.
C_LI
]]></description>
<dc:creator><![CDATA[ Sonjon, Y., Charriau, A., Mouhoub, D., Van der Henst, J.-B., Chabanat, E. ]]></dc:creator>
<dc:date>2026-11-09</dc:date>
<dc:identifier>doi:10.64898/2026.11.06.26367446</dc:identifier>
<dc:title><![CDATA[Negotiating the Social Self in Chronic Spinal Pain: A Qualitative Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.04.26367278v1?rss=1">
<title>
<![CDATA[
Clinician Counseling and Patient Storage and Disposal Practices for Opioids Prescribed for Acute Pain: A Multicenter Prospective Cohort Study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.04.26367278v1?rss=1
</link>
<description><![CDATA[
BACKGROUNDOpioids prescribed for acute pain frequently remain unused, creating opportunities for unintended use, accidental ingestion, or diversion. Little is known about counseling patients receive from prescribers or pharmacists on storage and disposal of opioids.

OBJECTIVETo characterize clinician counseling on opioid disposal and patient-reported storage, use, and disposal practices among opioid-naive patients prescribed opioids for acute pain.

DESIGNMulticenter prospective cohort study with participant recruitment between September 2020 and March 2023.

PARTICIPANTSOpioid-naive patients prescribed opioids for acute pain in emergency departments, primary care or urgent care clinics, inpatient settings, and dental practices.

MAIN MEASURESPatient-reported receipt of counseling on the importance of opioid disposal and appropriate disposal methods; opioid storage practices; use and disposition of prescribed opioids; disposal methods; and reasons for keeping or disposing of leftover opioids.

KEY RESULTSAmong 1708 participants, the median age was 38 years (IQR, 28-52); most were recruited from emergency departments (n=915; 53.6%) and primary care or urgent care clinics (n=307; 18.0%). Among 1233 participants who answered the question on counseling about the importance of opioid disposal, 811 (65.8%) reported receiving no counseling. Among 1220 participants who answered the question on counseling about appropriate disposal methods, 832 (68.2%) reported receiving no counseling. Among 812 participants who answered the question about storing opioids in a locked location, 610 (75.1%) reported never doing so. Among 929 participants providing information on opioid leftovers and disposition, 618 (66.5%) did not use all prescribed opioids. Among these 618 participants, 258 (42.8%) kept leftover opioids and 345 (57.2%) disposed of them. Among 256 participants who reported reasons for keeping leftover opioids, 159 (62.1%) wanted medication available for the same condition, 70 (27.3%) wanted medication available for a different condition, and 36 (14.1%) did not know how to properly dispose of the medication.

CONCLUSIONSAmong opioid-naive patients prescribed opioids for acute pain, counseling about opioid disposal was uncommon, secure storage was infrequent, and leftover opioids were frequent, with many patients keeping leftover opioids for possible future use. These findings suggest opportunities to improve counseling on opioid storage and disposal and encourage safe disposal of unused opioids after acute pain treatment.
]]></description>
<dc:creator><![CDATA[ Taherifard, E., Ahadpour, M., Bellolio, F., Chang, N., Allen, S., Elie-Turenne, M.-C., Fillmore, W. J., Gilbert, G. H., Heckmann, R., Koussis, P., Lee, C., Lipkind, H., Mallama, C., Meyer, T. E., Nuckols, T. K., Ritchie, J. D., Pacanowski, M. A., Page, D. B., Soukup, M., Tamang, S., Torbati, S., Wallace, D., Walter, L., Zhao, Y., Shah, N. D., Ross, J. S., Jeffery, M. M. ]]></dc:creator>
<dc:date>2026-11-05</dc:date>
<dc:identifier>doi:10.64898/2026.11.04.26367278</dc:identifier>
<dc:title><![CDATA[Clinician Counseling and Patient Storage and Disposal Practices for Opioids Prescribed for Acute Pain: A Multicenter Prospective Cohort Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.02.26367127v1?rss=1">
<title>
<![CDATA[
Balancing Analgesic Effects and Abuse Liability in Older Adults: A Randomized, Placebo-Controlled Trial of Oral and Vaporized Δ9-Tetrahydrocannabinol 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.02.26367127v1?rss=1
</link>
<description><![CDATA[
Cannabis use is rising fastest among older adults in the U.S., and pain is among the most common reasons they use it. No trial, however, has measured the trade-off between the analgesic and abuse-related effects of {Delta}9-tetrahydrocannabinol ({Delta}9-THC) in this population. In a randomized, double-blind, placebo-controlled trial, 20 adults aged 65 and older were assigned to oral {Delta}9-THC (placebo, 5, 10 mg) or vaporized {Delta}9-THC (placebo, 2, 4 mg) across three eight-hour sessions in counterbalanced order. We assessed laboratory-evoked pain sensitivity using quantitative sensory testing, abuse liability using subjective drug effects and reinforcement value, and also sampled plasma {Delta}9-THC and 11-OH-THC. Analgesia and abuse liability outcomes were measured repeatedly within each session. On a pain sensitivity index, oral 5 mg relieved pain relative to placebo (p=.040), although the oral arms overall dose effect was not significant (p=.108); oral 10 mg and both vaporized doses did not differ from placebo. Subjective effects increased with dose and were greatest after vaporization, whereas reinforcement value increased only after vaporized 4 mg. After oral 5 mg, analgesia exceeded placebo at every assessment (60-360 min), while its pleasurable effects peaked at 150 min. Vaporized {Delta}9-THC produced pleasurable effects within 30 min but did not significantly change thermal pain sensitivity. While abuse liability tracked {Delta}9-THC exposure, analgesia showed no significant association, and all adverse events occurred at vaporized 4 mg. These findings suggest dose and route selection may help maximize {Delta}9-THC analgesia while minimizing abuse liability, a strategy that warrants evaluation in clinical populations.
]]></description>
<dc:creator><![CDATA[ Costa, G. P. A., Gueorguieva, R., Riggs, M. M., Dunlap, T., Sofuoglu, M., De Aquino, J. P. ]]></dc:creator>
<dc:date>2026-11-04</dc:date>
<dc:identifier>doi:10.64898/2026.11.02.26367127</dc:identifier>
<dc:title><![CDATA[Balancing Analgesic Effects and Abuse Liability in Older Adults: A Randomized, Placebo-Controlled Trial of Oral and Vaporized Δ9-Tetrahydrocannabinol]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.27.26364954v1?rss=1">
<title>
<![CDATA[
Theta-band EEG changes following sequential rTMS and tACS in fibromyalgia: A randomized controlled pilot study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.27.26364954v1?rss=1
</link>
<description><![CDATA[
BackgroundSequential application of repetitive transcranial magnetic stimulation (rTMS) and transcranial alternating current stimulation (tACS) may induce neurophysiological changes within sensorimotor and pain-related networks. However, the resting-state EEG effects of this combined approach in fibromyalgia remain unknown.

MethodsIn this exploratory randomized controlled pilot study, 10 adults with fibromyalgia were assigned to active stimulation (n = 5) or a no-stimulation control group (n = 5). Active participants received one or two sessions of 10-Hz rTMS over the left primary motor cortex (1,000 pulses/session), followed by 10 daily sessions of bilateral 10-Hz tACS (1 mA, 20 min). Six-minute eyes-closed resting-state EEG recordings were obtained before and after the intervention or an equivalent control interval. Power spectral density was quantified in the delta, theta, alpha, and beta bands and analyzed using mixed repeated-measures ANOVAs across central-centroparietal and posterior regions of interest.

ResultsTheta power increased significantly in the active group but not in controls, yielding significant Time x Group (F(1,8)=8.70, p=.018, p{superscript 2}=.521) and Time x ROI x Group (F(1,8)=5.53, p=.047, p{superscript 2}=.409) interactions. Follow-up analyses showed increased theta power in both central-centroparietal (p=.004) and posterior (p=.012) regions, with a larger increase observed posteriorly. No significant interaction effects were found for delta, alpha, or beta power.

ConclusionsSequential motor-cortex rTMS followed by repeated bilateral 10-Hz tACS was associated with increased resting-state theta activity in fibromyalgia. Given the small sample size, post hoc ROI selection, lack of sham stimulation, and absence of component-specific control conditions, these findings should be considered hypothesis-generating and require replication in adequately powered sham-controlled studies.
]]></description>
<dc:creator><![CDATA[ Buran, O., Rostami Sani, B., Cabello, D., Montoya, P. ]]></dc:creator>
<dc:date>2026-10-28</dc:date>
<dc:identifier>doi:10.64898/2026.10.27.26364954</dc:identifier>
<dc:title><![CDATA[Theta-band EEG changes following sequential rTMS and tACS in fibromyalgia: A randomized controlled pilot study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.23.26366298v1?rss=1">
<title>
<![CDATA[
How much unplanned hospital activity is for people in their last year of life and how did the Covid-19 pandemic impact this? A 10-year population study for England (2014-2023) 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.23.26366298v1?rss=1
</link>
<description><![CDATA[
ObjectivesThe aim of this study is to investigate the impact of the Covid-19 pandemic on the proportion of unplanned hospital use that is for people in their last year of life in England, and to examine changes over time from 2014 to 2023.

DesignA whole population study using secondary analysis of linked routinely collected health data.

SettingEngland between 1st January 2014 and 31st December 2023.

ParticipantsAdults aged 18+ years using unplanned hospital care.

Main outcome measuresUnplanned hospital activity for people in their last year of life.

ResultsBetween 2014-2023, Emergency Department (ED) visits for people in their last year of life increased from 900,295 (6.2% of total) to 1,089,365 (6.1% of total); ambulance conveyances to the ED increased from 696,395 (17.3% of total) to 769,545 (19.5% of total); unplanned hospital admissions increased from 835,960 (18.0% of total) to 889,920 (16.4% of total); and unplanned hospital bed days increased from 11,180,815 (29.2% of total) to 11,491,915 (28.2% of total).

The Covid-19 pandemic was associated with an increase in the proportion of unplanned hospital admissions that were for people in their last year of life, with the largest increase observed among people living in more deprived areas (after adjusting for age and sex).

ConclusionsThese findings show that people in their last year of life account for a substantial proportion of demand for acute hospital and ambulance services. The changes observed during the Covid-19 pandemic underscore the need to consider end-of-life care needs when planning and delivering acute hospital services during periods of exceptional pressure. Improving the quality and coordination of end-of-life care across hospital and community care services should be a key consideration in efforts to meet the needs of an ageing population while managing pressures on the health system.

What is already known on the topic?O_LIFor people in their last year of life, unplanned hospital use is common and increases in the months before death.
C_LIO_LIVery little is known about how the proportion of unplanned hospital use for people who are in their last year of life has changed over time and in response to the Covid-19 pandemic.
C_LI

What this study addsO_LIApproximately one-third of unplanned hospital bed days are for people in their last year of life indicating that care of the dying is a core activity for hospitals.
C_LIO_LIThe increase in the proportion of unplanned hospital admissions that were for people in their last year of life during the Covid-19 pandemic, highlights the need to consider end-of-life care needs when planning services during periods of exceptional pressure.
C_LI
]]></description>
<dc:creator><![CDATA[ Davies, J. M., Verne, J., Bolton, T., Lewis, J., Chambers, R. L., Bone, A. E., Sleeman, K. E. ]]></dc:creator>
<dc:date>2026-10-26</dc:date>
<dc:identifier>doi:10.64898/2026.10.23.26366298</dc:identifier>
<dc:title><![CDATA[How much unplanned hospital activity is for people in their last year of life and how did the Covid-19 pandemic impact this? A 10-year population study for England (2014-2023)]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.25.26365740v1?rss=1">
<title>
<![CDATA[
An exploratory analysis of circulating cytokine profiles, pain-associated transcripts and autoantibody responses associated with treatment response in knee osteoarthritis 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.25.26365740v1?rss=1
</link>
<description><![CDATA[
BackgroundPain response to treatment in knee osteoarthritis (OA) varies substantially between individuals, but the biological factors underlying this heterogeneity remain poorly understood. We investigated whether circulating protein, transcriptional and autoantibody features were associated with variation in pain response to lifestyle interventions in people with knee OA.

MethodsWe performed an exploratory multi-modal analysis using participants from the INSPIRE randomised controlled trial and, for proteomic analyses, an independent WebEx cohort. Circulating inflammatory proteins were measured using Olink proximity extension assay at baseline and 6 weeks. Associations between baseline protein concentrations, longitudinal protein changes and pain response were assessed using multivariable regression, with multivariate protein patterns examined using supervised and sparse partial least squares approaches. Whole-blood transcriptomic data from INSPIRE were analysed using limma, restricted a priori to pain-associated genes represented in the Human Pain Genetics Database (HPGDB), with a responder-by-visit interaction used to assess differential longitudinal expression. Finally, exploratory IgG binding to murine satellite glial cells (SGCs) was assessed in selected INSPIRE participants with contrasting clinical responses to exercise.

ResultsNo circulating protein or transcriptomic association remained significant after correction for multiple testing. Several nominal associations were observed in the proteomic analyses, including baseline IL-10RA and CST5 in INSPIRE and OSM and TNFSF14 in WebEx. Longitudinal changes in IL-17A and TSLP were nominally associated with improvement in pain in INSPIRE, with a similar nominal association between IL-17A and pain improvement observed in WebEx. In the transcriptomic analysis, MMP9 showed the strongest nominal association with differential longitudinal expression according to pain response under both the {Delta}NRS [&le;] -1 (log2 fold change = 0.91, p = 0.008) and {Delta}NRS [&le;] -2 (log2 fold change = 1.02, p = 0.004) definitions; neither association remained significant following FDR correction. Exploratory SGC-binding analysis identified markedly increased baseline IgG binding in one participant with worsening pain, but this pattern was not consistently observed among other participants with poor clinical responses. Paired analyses provided no evidence of a consistent increase in SGC-binding IgG following exercise.

ConclusionsThis exploratory multi-modal analysis found no robust molecular signature of the pain response that survived correction for multiple testing. Nominal associations involving several circulating proteins, including IL-10RA, IL-17A and MMP9 provide potential leads for future investigation, but these findings should be interpreted cautiously given the multiple comparisons and limited sample sizes. Exploratory autoantibody analyses likewise provided no evidence of a consistent SGC-binding signature. Larger, independently powered studies are required to determine whether these candidate molecular features are reproducibly associated with treatment-related variation in pain response.
]]></description>
<dc:creator><![CDATA[ Franks, S., Kouraki, A., Kelly, T., Berwick, R., Neiland, H., Goebel, A., Valdes, A. ]]></dc:creator>
<dc:date>2026-10-26</dc:date>
<dc:identifier>doi:10.64898/2026.10.25.26365740</dc:identifier>
<dc:title><![CDATA[An exploratory analysis of circulating cytokine profiles, pain-associated transcripts and autoantibody responses associated with treatment response in knee osteoarthritis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.21.26366160v1?rss=1">
<title>
<![CDATA[
Trajectories and characteristics of pain in the first year after spinal cord injury: a TRACK-SCI study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.21.26366160v1?rss=1
</link>
<description><![CDATA[
Chronic pain affects most individuals with spinal cord injury (SCI) and frequently impairs daily function, and nearly half experience neuropathic pain. Neuropathic pain is commonly thought to develop months after injury and to persist once established. These views rest on classifying each patient as having neuropathic pain or not, although patients often report several pains. The same binary label is the usual target of prognostic and biomarker studies that aim to predict life-limiting pain. We tracked up to three of the worst pains per interview from injury to one year in 140 TRACK-SCI participants, using the DN4 interview (DN4i, threshold 3). Within three days of injury, half of all pain areas and three quarters of participants met the threshold, and pain-area prevalence changed little over the year. Individual pains, however, often changed. Only a third remained above the threshold throughout, one third resolved or fluctuated, and pains in the same person often followed different courses. At more than half of interviews with several pains, one pain met the threshold while another did not, so that the patients classification depended on the pain considered. We therefore derived a threshold-free Pain Composite Score from the DN4i items and pain intensity. The items formed a single dimension, and the composite was associated with sleep and mood interference whereas the binary classification was not. Neuropathic pain after SCI thus appears early, does not invariably persist, and differs between a persons pains, and graded pain-level measures may offer a more stable target for predicting life-limiting pain.

SummaryNeuropathic pain after spinal cord injury appears early and does not always persist. A threshold-free score, unlike binary classification, tracks how pain limits daily life.
]]></description>
<dc:creator><![CDATA[ Gumbel, J. H., Mendoza, E., Arellano, M., Huie, J. R., Hemmerle, D. D., Pascual, L. U., Singh, V., Keller, A. V., Bradfield, X., Weinstein, P. R., Bresnahan, J. C., Beattie, M. S., Ferguson, A. R., Kramer, J. L. K., Kyritsis, N., TRACK-SCI Investigators ]]></dc:creator>
<dc:date>2026-10-24</dc:date>
<dc:identifier>doi:10.64898/2026.10.21.26366160</dc:identifier>
<dc:title><![CDATA[Trajectories and characteristics of pain in the first year after spinal cord injury: a TRACK-SCI study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.20.26366046v1?rss=1">
<title>
<![CDATA[
Faster peak alpha frequency precedes higher menstrual pain in adolescence 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.20.26366046v1?rss=1
</link>
<description><![CDATA[
Brain differences in chronic pain are almost always measured after years of pain experience, leaving unresolved whether they create vulnerability to pain or result from it. Uniquely, menstrual pain has a developmentally scheduled onset (menarche, the first menstrual period), allowing the brain to be characterized before and after pain exposure occurs. Here we used longitudinal 64-channel EEG to measure resting brain activity in adolescents once before (n=250) and twice after (n=161, n=140) menarche. Before their first period, adolescents who later reported higher menstrual pain ([&ge;]30 on 0-100 VAS) already showed faster occipital peak alpha frequency compared to those who reported lower menstrual pain, a difference that persisted in the early (3 - 14 months) post-menarche time period. In contrast, oscillatory power and functional connectivity did not differ by menstrual pain group, suggesting that the widespread functional brain alterations reported in adults with painful periods take years to emerge. Peak alpha frequency increased, and theta power and connectivity decreased across the menarchal transition, consistent with typical adolescent maturation. However, longitudinal analyses stratified by higher and lower menstrual pain group suggested group specific timings for these neurodevelopmental changes. Overall, these findings suggest that early menstrual pain is not associated with widespread alterations in neural oscillations, but aspects of menstrual pain susceptibility may be reflected in resting peak alpha frequency. To our knowledge, this is the first neurophysiological trait shown to precede the onset of menstrual pain.
]]></description>
<dc:creator><![CDATA[ Osborne, N. R., Tu, F. F., Darnell, S. E., Kmiecik, M. J., Hellman, K. M. ]]></dc:creator>
<dc:date>2026-10-22</dc:date>
<dc:identifier>doi:10.64898/2026.10.20.26366046</dc:identifier>
<dc:title><![CDATA[Faster peak alpha frequency precedes higher menstrual pain in adolescence]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.20.26366024v1?rss=1">
<title>
<![CDATA[
Temporal associations between pain and anxiety/depression in young people: A systematic review and meta-analysis of longitudinal, prospective, population- and community-based studies 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.20.26366024v1?rss=1
</link>
<description><![CDATA[
Pain, anxiety, and depression are common among young people, frequently co-occur with each other, and may be longitudinally related. This systematic review and meta-analysis aimed to synthesise the direction and strength of the temporal associations between pain and anxiety/depression among young people. PsycINFO, Web of Science, Scopus, PubMed, Proquest Dissertations and Theses, Google Scholar, and OSF Preprints were searched from inception until 3 July 2026. Additional studies were identified through citation searching and references of existing systematic reviews. Longitudinal, prospective, population-or community-based studies examining temporal associations between pain and anxiety/depression among young people (0-24 years) were included. Two independent reviewers screened studies, extracted data, assessed risk of bias using ROBINS-E, and evaluated certainty of evidence using GRADE. Data were synthesised using three-level meta-analysis and narrative synthesis. Forty-two studies from 31 longitudinal cohorts were included. Anxiety, depression, and combined anxiety/depression were positively associated with subsequent pain. However, after adjustment for confounders, only depression remained significantly associated. Pain was positively associated with subsequent anxiety, depression, and combined anxiety/depression both before and after confounder adjustment. Heterogeneity was moderate to considerable and was partly explained by sex, baseline age, follow-up duration, pain type, pain informant, pain and anxiety/depression operationalisation, and risk of bias. Two of 14 outcomes had high quality of evidence, whereas the remainder ranged from very low to moderate quality. These findings highlight longitudinal associations between pain and anxiety/depression among young people and should be considered in the screening, treatment, and public health management of these problems.
]]></description>
<dc:creator><![CDATA[ Tran, T. V. H., Harding, R. P., Rowney-Smith, A., Can, B., Reynolds, J., Matcham, F., Lester, K. J., Thompson, E. J. ]]></dc:creator>
<dc:date>2026-10-22</dc:date>
<dc:identifier>doi:10.64898/2026.10.20.26366024</dc:identifier>
<dc:title><![CDATA[Temporal associations between pain and anxiety/depression in young people: A systematic review and meta-analysis of longitudinal, prospective, population- and community-based studies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.20.26365979v1?rss=1">
<title>
<![CDATA[
Drug exposure during oxycodone-S-ketamine patient-controlled analgesia reflects pain-related dosing behaviour after lumbar fusion surgery 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.20.26365979v1?rss=1
</link>
<description><![CDATA[
BackgroundOpioids remain the cornerstone of acute postoperative pain management but are associated with potentially serious adverse effects. We aimed to investigate the effect of oxycodone patient-controlled analgesia with adjunctive S-ketamine on pain after lumbar fusion surgery.

MethodsIn this secondary analysis, we examined oxycodone and S-ketamine exposure and PCA behaviour during the first 24 h. We assessed current pain versus subsequent PCA activity and whether the association between plasma oxycodone and adequate analgesia changed with postoperative time.

ResultsPlasma concentrations of administered drugs rose rapidly after PCA initiation, but variation was large. Metabolite concentrations accumulated over time. PCA attempt and delivered-dose rates decreased over postoperative time (RR 0.965 and 0.966 per hour, respectively; both P<0.001). Older age was associated with a lower delivered-dose rate (RR 0.905 per 10 years, 95% CI 0.829-0.987). Each 1-point higher current pain score was associated with more subsequent PCA attempts (RR 1.09, 95% CI 1.04-1.14) and delivered doses (RR 1.07, 95% CI 1.03-1.11). The oxycodone-analgesia association weakened over time [interaction P <0.001; odds ratios (Ors) per 10 ng/mL 1.16, 1.13, and 1.00 at 1, 4, and 24 h, respectively]. In active S-ketamine groups, including S-ketamine, norketamine, and 6-hydroxynorketamine concentrations left the pain-PCA association unchanged (RR 1.09 and 1.07) and preserved the time-dependent oxycodone association (ORs 1.30, 1.26, and 1.02).

ConclusionsDuring PCA, drug exposure develops from patient-generated dosing histories while pain and recovery change. Current pain was associated with subsequent PCA activity, and the oxycodone-analgesia association was time-dependent.
]]></description>
<dc:creator><![CDATA[ Virtanen, T., Brinck, E. C. V., Engstrom, M., Kurkela, M. J., Tarkkila, P., Backman, J., Tornio, A., Kontinen, V., Peltoniemi, M., Saari, T. I. ]]></dc:creator>
<dc:date>2026-10-21</dc:date>
<dc:identifier>doi:10.64898/2026.10.20.26365979</dc:identifier>
<dc:title><![CDATA[Drug exposure during oxycodone-S-ketamine patient-controlled analgesia reflects pain-related dosing behaviour after lumbar fusion surgery]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.16.26365778v1?rss=1">
<title>
<![CDATA[
Predictors of methadone response in chronic neuropathic pain 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.16.26365778v1?rss=1
</link>
<description><![CDATA[
BackgroundAlthough opioids are frequently prescribed for refractory chronic neuropathic pain, few data are available on baseline factors that may identify individuals more likely to respond and inform individually tailored practice.

MethodsThis was a post hoc, exploratory analysis of individual-level data from a placebo-controlled trial of methadone for chronic neuropathic pain (NCT05235191). Baseline clinical, psychological, psychophysical and radiological variables were tested for association with [&ge;]30% pain reduction in the methadone group. The correlation between expectation of improvement and pain reduction was examined in both groups.

ResultsOf the 81 participants completing the 8-week follow-up, 28 (70%) on methadone and 14 (34.1%) on placebo achieved [&ge;]30% pain reduction. In the methadone group, responders had higher baseline expectation of improvement (median 100 [80-100] vs. 55 [50-81]; p=0.004), which correlated moderately with percentage pain reduction (rs=0.508; p<0.001). Neither finding was observed in the placebo group (p=0.211 and p=0.161, respectively), although the correlation did not differ significantly between groups (p for interaction=0.728). Other clinical, sociodemographic, psychological and psychophysical variables were not associated with response. In the subsample with peripheral neuropathic pain and structural MRI (n=37), lower left precentral cortex volume was associated with response to methadone (p=0.041), and lower right paracentral volume with response to placebo (p=0.003).

ConclusionsBaseline expectation may influence treatment outcomes, supporting its inclusion as a covariate to improve the precision of treatment effect estimates in trials, and its use in clinical practice to help tailor treatment to individual patients. These exploratory findings require confirmation in larger studies.

Significance statementPredictors of opioid response in chronic neuropathic pain remain poorly understood, and treatment expectation has received little attention in this setting. In this study, a single baseline rating of expected improvement identified methadone responders more consistently than pain phenotype, conditioned pain modulation or other psychological traits. These results support considering patient expectation both when interpreting opioid trials and when discussing likely benefit with patients before starting treatment.
]]></description>
<dc:creator><![CDATA[ Barbosa, M. M., Pentiado, J. A. M., Kubota, G., Martins, P. N., Moreira, L. I., Fernandes, A. M., da Silva, V. A., Junior, J. R., Figueiredo, E. G., Yeng, L. T., Teixeira, M. J., de Andrade, D. C. ]]></dc:creator>
<dc:date>2026-10-21</dc:date>
<dc:identifier>doi:10.64898/2026.10.16.26365778</dc:identifier>
<dc:title><![CDATA[Predictors of methadone response in chronic neuropathic pain]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.13.26365452v1?rss=1">
<title>
<![CDATA[
Daily personalized music listening versus audiobook listening for chronic non-cancer pain in patients on long-term opioid therapy: a randomized controlled trial 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.13.26365452v1?rss=1
</link>
<description><![CDATA[
Non-pharmacological adjuncts are needed for chronic non-cancer pain in patients receiving long-term opioid therapy. Music listening may reduce pain, but most previous trials have used passive controls, limiting attribution of effects specifically to music. In this open-label, parallel-group, proof-of-concept randomized controlled trial, adults with chronic non-cancer pain receiving long-term opioid therapy were randomized 1:1 to four weeks of daily home-based music or audiobook listening. Analgesic outcomes included pain intensity, responder rates, quantity of pain relief, and multidimensional pain assessment; secondary outcomes included mood, quality of life, global impression of change, and safety. Of 70 participants entering the run-in period, 56 were randomized (28 per group). Adjusting for baseline pain intensity in a linear mixed-effects model, the between-group difference at end of treatment was -1.26 NRS points (95% CI -1.98 to -0.55; p<0.001; d=-0.70), favoring music. A [&ge;]30% pain-reduction criterion was met by 21.4% of participants in the music group and none in the audiobook group (p=0.023). An exploratory between-group difference in pain intensity favoring music was also observed at follow-up. Other analgesic and secondary outcomes showed no significant between-group differences, although exploratory within-group improvements in mood and health-related quality of life were observed with music. Both groups reported overall improvement in global perceived change, with ratings numerically favoring music. No intervention-related harms were observed. These findings support an analgesic benefit of music beyond the structured listening experience shared with the active comparator. Daily self-administered music listening may represent a feasible, low-cost adjunct for chronic non-cancer pain in patients receiving long-term opioid therapy.
]]></description>
<dc:creator><![CDATA[ Garrido-Pedrosa, J., Porto, M. F., Serrano-Afonso, A., Valenzuela, R., Zapata, L., Vidal, M. F., Luna-Diaz, P., Segura, E., Cerda-Company, X., Videla, S., Rodriguez-Fornells, A., Grau-Sanchez, J., Fernandez-Duenas, V. ]]></dc:creator>
<dc:date>2026-10-14</dc:date>
<dc:identifier>doi:10.64898/2026.10.13.26365452</dc:identifier>
<dc:title><![CDATA[Daily personalized music listening versus audiobook listening for chronic non-cancer pain in patients on long-term opioid therapy: a randomized controlled trial]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.10.26365209v1?rss=1">
<title>
<![CDATA[
Longitudinal Pain Profiles and Their Clinical and Genetic Correlates in 624,996 U.S. Veterans 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.10.26365209v1?rss=1
</link>
<description><![CDATA[
ImportancePain varies in its intensity and course, yet much of our understanding of pain is based on cross-sectional assessments or longitudinal studies of selected clinical populations. Routinely collected electronic health record data may enable characterization of longitudinal pain patterns at scale.

ObjectiveTo identify longitudinal pain profiles among U.S. Veterans and characterize their clinical and polygenic correlates.

DesignCohort study using electronic health record and genomic data from the Million Veteran Program, with up to 16 years of pain assessments collected between 2000 to 2025.

SettingU.S. Department of Veterans Affairs health care system.

ParticipantsMillion Veteran Program participants assigned to African-like, Admixed American-like, East Asian-like, European-like, or South Asian-like genetically inferred ancestry groups who have at least three years of outpatient numeric rating scale pain records.

ExposuresOutpatient pain ratings and polygenic scores for psychiatric, sleep, and substance use traits.

Main Outcomes and MeasuresPain profiles were identified using Gaussian finite mixture modeling of pain intensity, directional change, and within-person variability. Profiles were characterized by pain, psychiatric and substance use diagnoses, opioid exposure, body mass index, and polygenic scores.

ResultsAmong 624,996 participants (Mean [SD] age at first pain rating=53.4 [13.5] years; 568,833 [91.0%] male), 51,731,567 outpatient pain ratings were analyzed. Three profiles were identified: stable no pain, stable mild pain, and mild-to-moderate increasing pain. Compared with the stable no pain profile, the increasing pain profile had higher odds of chronic pain (OR=21.14 [95% CI: 18.96-23.57]), opioid use disorder (OR=9.32 [95% CI: 8.31-10.45]), opioid exposure (OR=8.61 [95% CI: 8.41-8.83]), major depressive disorder (OR=3.77 [95% CI: 3.67-3.87]), and posttraumatic stress disorder (OR=3.72 [95% CI: 3.61-3.84]). Associations were attenuated but remained after adjustment for mean pain severity. Polygenic scores for depression, insomnia, attention-deficit/hyperactivity disorder, and tobacco use disorder were the most consistent predictors of increasing pain across the three largest genetically inferred ancestry groups.

Conclusions and RelevanceLongitudinal modeling of routinely collected pain scores identified pain profiles associated with clinical burden and polygenic liability. These profiles captured clinically meaningful information beyond mean pain severity alone, highlighting the value of longitudinal pain phenotyping in electronic health record data.

Key PointsO_ST_ABSQuestionC_ST_ABSCan pain scores collected in outpatient care identify clinically meaningful pain profiles among U.S. Veterans?

FindingsIn this cohort study of 624,996 Veterans with more than 51 million pain ratings across up to 16 years, three pain profiles were identified: stable no pain, stable mild pain, and mild-tomoderate increasing pain. Profiles differed in clinical burden even after accounting for mean pain severity and were associated with polygenic liability for psychiatric, sleep, and substance use traits.

MeaningRoutinely collected pain scores can be used to characterize heterogeneity in the course of pain and factors associated with more burdensome pain patterns.
]]></description>
<dc:creator><![CDATA[ Davis, C. N., Shi, M., Gunawan, T., Toikumo, S., Million Veteran Program,, Gray, J., Kranzler, H. ]]></dc:creator>
<dc:date>2026-10-12</dc:date>
<dc:identifier>doi:10.64898/2026.10.10.26365209</dc:identifier>
<dc:title><![CDATA[Longitudinal Pain Profiles and Their Clinical and Genetic Correlates in 624,996 U.S. Veterans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.08.26365039v1?rss=1">
<title>
<![CDATA[
Impact of self-reported interoceptive abilities on postoperative pain 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.08.26365039v1?rss=1
</link>
<description><![CDATA[
Interoception is described as the sensitivity to internal bodily stimuli, and plays an important role in pain perception. Heightened interoceptive sensibility (i.e. self-reported interoceptive abilities) may reinforce misinterpretation of stimuli, enhancing pain perception. This study aimed to investigate the relationship between interoceptive sensibility and acute postoperative pain. Interoceptive sensibility was measured using the Private Body Consciousness Scale in two prospective observational surgical cohorts: a Caesarean delivery cohort (C-section cohort) of 146 patients, and a lower extremity orthopaedic surgery cohort (Ortho cohort) of 70 patients. One day after surgery, patients rated pain (primary outcome) and other postoperative symptoms (secondary outcomes) on a 0-10 scale. Bonferroni corrections were applied to secondary outcomes. Interoception positively correlated with pain (C-section cohort: Spearmans rho = 0.182, P = 0.028; Ortho cohort: rho = 0.259, P = 0.031), and with dizziness (C-section cohort: rho = 0.309, P = 0.002; Ortho cohort: rho = 0.348 P = 0.041) in both cohorts. In the C-section cohort, interoception correlated with shivering (rho = 0.321, P < 0.001). In the Ortho cohort, interoception correlated with nausea (rho = 0.366, P = 0.023) and helplessness (rho = 0.363, P = 0.026); whereas no correlation with pain catastrophising was found (rho = 0.240, P = 0.539). In pooled multiple linear regression analysis (n = 216), interoception predicted pain after controlling for age, sex and anaesthetic technique (B = 0.119, 95% CI [0.027-0.210], P = 0.011). These findings highlight the potential role of interoception in identifying patients at risk for acute postsurgical pain.

PerspectiveThis study identified associations between self-reported interoceptive abilities and acute postsurgical pain in two independent cohorts. These findings could contribute to the understanding of individual differences in pain perception, and provide an initial foundation for exploring the effectiveness of interoceptive therapies in preventing severe postoperative pain.
]]></description>
<dc:creator><![CDATA[ Weldam, B. P., Meijer, L. L., van den Bosch, O. F. C., van Driel, M. E. C., Timmerman, L., van Dijk, J. F. M., Strick, M., IPOP research group,, Rijsdijk, M. ]]></dc:creator>
<dc:date>2026-10-11</dc:date>
<dc:identifier>doi:10.64898/2026.10.08.26365039</dc:identifier>
<dc:title><![CDATA[Impact of self-reported interoceptive abilities on postoperative pain]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.07.26364942v1?rss=1">
<title>
<![CDATA[
Persistent Fibromyalgia-like symptom presentation in Long COVID-associated chronic musculoskeletal pain: a longitudinal cohort study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.07.26364942v1?rss=1
</link>
<description><![CDATA[
BackgroundChronic musculoskeletal pain (CMP) is a common and debilitating symptom of Long COVID (LC), which shares several clinical features with Fibromyalgia Syndrome (FMS).

AimsThis longitudinal study investigated whether the symptom overlap between LC-CMP and FMS persists over time, whether patterns differ according to pre-COVID CMP history, and the extent to which neuropathic pain features are present.

MethodsIndividuals with LC completed questionnaires assessing the symptom-based component of the 2010 American College of Rheumatology criteria for FMS and the presence of neuropathic pain features (PainDetect Questionnaire, PDQ) at baseline, 6- and 12-month follow-ups. Participants were grouped according to pre-COVID CMP history. Group differences were analysed using mixed-effects logistic regression.

Results240 individuals completed the baseline assessment at a mean of 2.61 years after LC onset, including 131 (100 females) with new-onset CMP and 94 (87 females) with pre-existing CMP. The prevalence of participants meeting the symptom-based criteria for FMS remained high across follow-up (67.5-78.6%), with 50.0-61.0% of those with complete follow-up data fulfilling criteria at all timepoints. No significant subgroup differences were observed (OR = 0.43, 95% CI [0.14 1.39], p = 0.160). Across follow-up, 22.2-36.1% of participants reported likely neuropathic pain features, with significantly higher odds in the pre-existing CMP group (OR = 3.17, 95% CI [1.22 8.18], p = 0.017).

ConclusionsFMS-like symptoms remain highly prevalent several years after acute COVID-19 and persist over a further 12 months, suggesting that LC-CMP frequently represents a persistent long-term condition with substantial overlap with FMS. These findings support closer integration of LC and chronic pain rehabilitation services and add to the wider literature linking post-infectious processes with FMS-like symptoms.
]]></description>
<dc:creator><![CDATA[ Silva-Passadouro, B., Delis, I., Astill, S. L., Brown, C., Casson, A. J., Sivan, M. ]]></dc:creator>
<dc:date>2026-10-08</dc:date>
<dc:identifier>doi:10.64898/2026.10.07.26364942</dc:identifier>
<dc:title><![CDATA[Persistent Fibromyalgia-like symptom presentation in Long COVID-associated chronic musculoskeletal pain: a longitudinal cohort study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.02.26364550v1?rss=1">
<title>
<![CDATA[
Emergency Department Utilization After 60-Day Peripheral Nerve Stimulation Versus Usual Care for Refractory Occipital Neuralgia: A Prospective Propensity-Matched Cohort, Difference-in-Differences Analysis 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.02.26364550v1?rss=1
</link>
<description><![CDATA[
BackgroundTemporary 60-day percutaneous peripheral nerve stimulation (PNS) can relieve pain in refractory occipital neuralgia (ON), but whether it alters acute healthcare utilization relative to the natural trajectory of the disease is unknown, because prior studies have lacked a concurrent comparator.

MethodsWe performed a secondary analysis of prospectively collected data from a tertiary interventional pain center. Adults with medically refractory ON (primary diagnosis occipital neuralgia, ICD-10-CM M54.81) who underwent 60-day occipital PNS (n = 42) were compared with concurrent patients who were clinically eligible for PNS but were denied insurance authorization and continued optimized non-PNS management (usual care; n = 63). Headache-related emergency department (ED) encounters--index (occipital neuralgia) and non-index (other headache/facial-pain diagnoses)--were ascertained over the 12 months before and after the treatment window via the electronic record and the statewide health information exchange. Patients were 1:1 propensity-matched on a priori confounders (age, sex, baseline total headache-related ED utilization, HIT-6, and baseline headache-medication use). The primary analysis was a difference-in-differences (DiD) comparison of the change in headache-related ED utilization, reported as the additive difference (Hodges- Lehmann estimate, distribution-free 95% CI) and, alongside, as a multiplicative rate ratio (RR).

ResultsThirty-six matched pairs were well balanced. Baseline headache-related ED utilization was nearly identical between matched groups (6.3 vs. 6.2 visits/year). Over the following year, PNS patients utilization fell to 2.5 while usual-care patients rose to 6.9. The DiD was 5.0 fewer headache-related ED visits per patient (95% CI 3.0-6.0; p < 0.001), corresponding to a rate ratio of 0.36 (95% CI 0.27-0.48; p < 0.001). Results were consistent in the full sample, in covariate-adjusted models, and after excluding controls denied for incomplete conservative-therapy trials. The effect was driven by non-index headache visits.

ConclusionsRelative to a concurrent, matched usual-care cohort whose headache-related ED utilization rose over time, 60-day occipital PNS was associated with a substantial reduction in acute-care use, strengthening the case for a role of PNS on healthcare utilization in refractory ON.
]]></description>
<dc:creator><![CDATA[ Harris, C. W., Nguyen, E. T., Limas, S. M., Sheth, S. J., Chow, R. W., Odonkor, C. A. ]]></dc:creator>
<dc:date>2026-10-06</dc:date>
<dc:identifier>doi:10.64898/2026.10.02.26364550</dc:identifier>
<dc:title><![CDATA[Emergency Department Utilization After 60-Day Peripheral Nerve Stimulation Versus Usual Care for Refractory Occipital Neuralgia: A Prospective Propensity-Matched Cohort, Difference-in-Differences Analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.28.26364170v1?rss=1">
<title>
<![CDATA[
Meeting the needs of people with pulmonary fibrosis: patient perspectives on improving palliative care provision: a qualitative study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.28.26364170v1?rss=1
</link>
<description><![CDATA[
BackgroundPalliative care is suboptimal in pulmonary fibrosis. Symptom burden is high despite evidence-based interventions, guidelines, and information resources. The application of existing knowledge and methods to optimally manage palliative and end of life care for people with pulmonary fibrosis in the UK has not been realised.

AimTo establish patient views and understanding of how palliative care services and approaches can better meet the needs of people with pulmonary fibrosis. To identify the current barriers and facilitators to receiving palliative care services.

DesignQualitative exploration of patient views via semi-structured interviews and focus groups. Content analysis was conducted.

Setting/ParticipantsThe study was conducted from March-August 2024 within an Interstitial Lung Disease Specialist Centre, based in an NHS acute Trust.

ResultsTwo focus groups and four interviews were conducted, involving nine patients. Four overarching themes were identified as to how palliative care can better meet the needs of this group: (1) establishing mechanisms for identifying and addressing palliative care needs; (2) open channels of communication with healthcare professionals; (3) the importance of a palliative care approach within respiratory, community and specialist services; and (4) support for unpaid/family carers.

ConclusionsPatients highlighted the importance of person-centred principles and services that adapted to their needs (such as real-time telephone support), rather than services that imposed their own requirements on the patients. Understanding how existing palliative care provision can meet this standard could help improve the palliative and end of life care for people with pulmonary fibrosis.

Key StatementO_ST_ABSWhat is already known about this topic?C_ST_ABSO_LIPulmonary fibrosis is associated with significant patient and carer need, and high symptom burden
C_LIO_LIPulmonary fibrosis is associated with poor outcomes relevant to palliative care, with limited use of advance care plans (ACP), high levels of end-stage healthcare utilisation, frequent hospital deaths and poor symptom control.
C_LIO_LIThere is consensus that palliative care is beneficial for this condition, but the model of care required is not clear.
C_LI

What this paper adds?O_LIPatients with pulmonary fibrosis do not readily distinguish between the care they receive from the specialist respiratory services and that which they receive from palliative care services.
C_LIO_LIAccessibility of services is of key importance in addressing palliative care needs.
C_LIO_LIPerson-centred principles are critical to ensure that services reflect the varying information and care needs of this population.
C_LI

Implications for Practice, Theory or PolicyO_LIA "one size fits all" approach to palliative care is unlikely to meet the needs of people with pulmonary fibrosis.
C_LIO_LIProvision for remote real-time telephone or video contact is important for this group who, due to oxygen and other care needs, may find hospital visits challenging.
C_LIO_LIMore work is needed to understand how palliative care services and approaches can best meet the needs of unpaid/family carers who support people with pulmonary fibrosis.
C_LI
]]></description>
<dc:creator><![CDATA[ Barry, C., Gardener, C., Farquhar, M., Karwa, I., Wilson, A. ]]></dc:creator>
<dc:date>2026-10-02</dc:date>
<dc:identifier>doi:10.64898/2026.09.28.26364170</dc:identifier>
<dc:title><![CDATA[Meeting the needs of people with pulmonary fibrosis: patient perspectives on improving palliative care provision: a qualitative study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.28.26364225v1?rss=1">
<title>
<![CDATA[
Relevance-Based Prediction: A Transparent, Patient-SpecificApproach to Predicting Medical Outcomes 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.28.26364225v1?rss=1
</link>
<description><![CDATA[
Accurate prediction of individual medical outcomes is essential for optimizing treatment allocation amid rising costs, coverage denials, and limited clinical resources. Traditional predictive models, including linear regression and neural networks, rely on average effects and cannot tailor predictions to the specific circumstances of individual cases. We present relevance-based prediction (RBP), a model-free and task-specific method that predicts outcomes as weighted averages of observed cases, with weights determined by a rigorously defined and theoretically justified measure of relevance. Unlike model-based methods that rely on fixed calibrated parameters, relevance-based prediction revisits the original data for each prediction and customizes both the cases and variables used. We illustrate RBP by applying it to predict opioid treatment outcomes and demonstrate that it provides case-specific insights unavailable from conventional models, including how each prior case informs a prediction, how each variable affects each predictions reliability and value, and how reliable each prediction is before it is made. These individualized insights may prevent misleading average-based decisions and reduce harmful or suboptimal treatment.
]]></description>
<dc:creator><![CDATA[ Robinson, C. L., Turkington, D., Lee, L., Kritzman, M., Yong, R. J. ]]></dc:creator>
<dc:date>2026-09-30</dc:date>
<dc:identifier>doi:10.64898/2026.09.28.26364225</dc:identifier>
<dc:title><![CDATA[Relevance-Based Prediction: A Transparent, Patient-SpecificApproach to Predicting Medical Outcomes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.29.26364287v1?rss=1">
<title>
<![CDATA[
Six recommendations for improving care and support in advanced COPD: evidenced from a population-based, mixed method, multiple-perspective, longitudinal study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.29.26364287v1?rss=1
</link>
<description><![CDATA[
BackgroundChronic obstructive pulmonary disease (COPD) is a progressive condition with high symptom burden. Advanced COPD management should relieve symptoms, optimise daily functioning and reduce carer burden, yet there is limited enactment of policy-advocated person-centred approaches to care and support. The Living with Breathlessness Study sought to establish evidence-based recommendations to inform a new paradigm to improve care and support in advanced COPD.

MethodsComprehensive multiple-perspective longitudinal evidence was collected on care, support, functioning and needs in advanced COPD from a population-based cohort of over 500 patients, their unpaid/family carers and health care professionals through semi-structured interviews and validated outcome measures over an 18-month period. Quantitative data analysed using standard descriptive statistics, numerical and univariate analyses, and qualitative data using a Framework approach.

Recommendations were then generated through three linked strategies: (1) an expert multidisciplinary group, (2) a stakeholder workshop and (3) a stakeholder survey.

ResultsSix inter-related recommendations emerged, linked by the concept of proactive person-centred care, supported by action points to enable delivery. Recommendations in brief: (1) stop focusing on the challenge of prognostication as a barrier to meeting need, (2) change targets to incentivise person-centred care, (3) enable identification of patient support needs, (4) identify and support carers, (5) identify and respond to psychological morbidity, (6) change societal understandings of COPD, breathlessness, palliative care and informal carers. The recommendations garnered significant support from stakeholders, with caution regarding ease of implementation.

ConclusionsEnactment of the resulting six evidence-based recommendations, through their action points, could inform a new paradigm to improve care and support in advanced COPD recognising the slow relentless progression of non-malignant disease, and its effect on patients and their carers. They hold potential for other patients and unpaid/family carers who are living in between conventional disease management and end-of-life care, and for those HCPs striving to support them.
]]></description>
<dc:creator><![CDATA[ Farquhar, M., Ewing, G., Moore, C., Gardener, C., Holt Butcher, H., Burge, P., Ling, T., Living with Breathlessness Study Team ]]></dc:creator>
<dc:date>2026-09-30</dc:date>
<dc:identifier>doi:10.64898/2026.09.29.26364287</dc:identifier>
<dc:title><![CDATA[Six recommendations for improving care and support in advanced COPD: evidenced from a population-based, mixed method, multiple-perspective, longitudinal study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.24.26363855v1?rss=1">
<title>
<![CDATA[
The Context of Recovery Among Adults Who Recover from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-COVID Condition Following Mind-Body Approaches: A Qualitative Descriptive Study Protocol 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.24.26363855v1?rss=1
</link>
<description><![CDATA[
BackgroundMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and post-COVID condition are complex, debilitating illnesses characterized by persistent fatigue and post-exertional malaise. Recovery is uncommon without targeted intervention; however, emerging clinical reports suggest that a subset of patients experience full resolution of symptoms after engaging in mind-body approaches. Patient perspectives on these interventions are divided, and qualitative evidence exploring successful recovery pathways is rare. This protocol outlines a study to investigate the contextual factors and patient-constructed explanations surrounding full recovery from ME/CFS or post-COVID condition using mind-body approaches.

Methods and analysisWe will employ a qualitative descriptive design rooted in a constructivist paradigm. Purposive and snowball sampling will be used to recruit approximately 20 adults from established infection-associated fatigue networks who self-report full recovery (lasting three months or more) from ME/CFS or post-COVID condition following a mind-body approach. Data will be collected through semi-structured interviews conducted via Zoom, and investigator reflexivity will be reported. Demographic information, including comorbidities, will be documented to contextualize the sample. Data will be analyzed inductively using reflexive thematic analysis. To ensure research rigor and reporting transparency, the study will adhere to the 15-point checklist of criteria for good thematic analysis proposed by Braun and Clarke.

DisseminationWe will publish our findings in a peer-reviewed, open-access journal and present at relevant academic conferences. A lay summary of the results will also be shared directly with participating patient recovery networks.
]]></description>
<dc:creator><![CDATA[ Cordovani, L., Almazyad, L., Zeraatkar, D., Busse, J. W. ]]></dc:creator>
<dc:date>2026-09-25</dc:date>
<dc:identifier>doi:10.64898/2026.09.24.26363855</dc:identifier>
<dc:title><![CDATA[The Context of Recovery Among Adults Who Recover from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-COVID Condition Following Mind-Body Approaches: A Qualitative Descriptive Study Protocol]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.23.26363767v1?rss=1">
<title>
<![CDATA[
EasyCog: a fast and effective numerical tool for the self-assessment of cognitive functions 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.23.26363767v1?rss=1
</link>
<description><![CDATA[
Many pathological conditions, including chronic pain (CP), can impair cognitive functions. These functions are essential for adapting and evolving in concordance with the environment, which are key processes for coping with CP. However, in CP centers, cognitive assessment is rarely included in CP patient follow-up due to a lack of time, appropriate tools, or trained health professionals. To fill this gap, our team developed EasyCog, a digital tool that enables rapid self-assessment of cognitive functions. It enables cognitive evaluation without an experimenters help, thanks to speech recognition powered by an artificial neural network. In the initial validation steps, we established normative values for 7 cognitive functions on a cohort of 76 healthy subjects. Because EasyCog includes tests comparable to the Montreal Cognitive Assessment (MoCA) and the Mini-Mental State Examination (MMSE), we assessed its reliability against available normative values. To assess its specificity, we compared data from healthy subjects with 15 subjects with mild cognitive impairment (MCI) and 15 age-matched CP patients selected from a medical center. Finally, we tested EasyCogs test-retest reliability by repeating sessions at different time intervals. EasyCog showed excellent sensitivity to age-related decline, similar to MoCA normative values. Several cognitive functions were significantly and differentially impaired in MCI subjects and CP patients compared to normative values in healthy subjects, confirming good specificity. Finally, test-retest analysis showed no effect at a 4-month interval. In conclusion, EasyCog appears to be a convenient and reliable numeric tool for rapidly assessing and monitoring cognitive functions in patients.
]]></description>
<dc:creator><![CDATA[ Hadri, L., Lejczak, S., Fabian, X., Martinie, O., Justin, G., Lithfous, S., Salvat, E., Nizard, J., Poisbeau, P. ]]></dc:creator>
<dc:date>2026-09-24</dc:date>
<dc:identifier>doi:10.64898/2026.09.23.26363767</dc:identifier>
<dc:title><![CDATA[EasyCog: a fast and effective numerical tool for the self-assessment of cognitive functions]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.1101/2025.10.28.25336335v1?rss=1">
<title>
<![CDATA[
Healthcare Worker s (HCWs) Knowledge and Attitudes Related to Pain Management in a Lebanese Tertiary Hospital 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.1101/2025.10.28.25336335v1?rss=1
</link>
<description><![CDATA[
OBJECTIVEThis study aims to evaluate the knowledge and attitudes of healthcare workers (HCWs) regarding pain assessment and management at a tertiary medical centre in Beirut, Lebanon as well as to identify areas for improvement.

DESIGNA cross-sectional study was conducted with Healthcare Workers using the "Knowledge and Attitudes Survey Regarding Pain" (KASRP), a validated practice-based questionnaire. This specific tool was used to assess the participants knowledge and attitudes related to pain management. Descriptive statistics were presented as frequencies, percentages, means, and standard deviations. Independent samples t-tests or ANOVA tests were used to compare mean knowledge scores between groups. A p-value of < 0.05 was considered statistically significant.

SETTINGThe study was conducted over a period of 1 month at a private tertiary hospital in Beirut, Lebanon.

PARTICIPANTSThe study included physicians, nurses, and pharmacists working in different departments within the hospital: Internal Medicine, Pharmacy, Nursing, and Quality Management.

RESULTSA total of 161 HCWs participated in the study (41 physicians, 100 nurses, and 20 pharmacists). The overall mean KASRP score obtained across all participants was 13.65 (SD = 9.93) for correct responses, indicating a moderate level of knowledge. Only 9 participants (5.6%) scored [&ge;]80%, which is considered as a satisfactory level of knowledge and attitude: 4 doctors (9.8%), 5 nurses (5%), and no pharmacists. Items of the KASPR score were categorized into 5 domains: assessment, medication, addiction, spiritual considerations and interventions. Variables potentially affecting knowledge and attitude towards pain management were analyzed: gender, age, profession, prior training on pain management, and years of experience. There was no statistical significance in the mean score of correct answers based on gender, prior training, or years of experience (p >0.05). However, age and profession showed a statistical significance of impact on the mean score of correct answers among HCWs (P <0.05), suggesting that these factors may influence pain management understanding among HCWs

CONCLUSIONThe findings highlight gaps in knowledge and attitudes toward pain management among HCWs. Structured education and training programs on pain management are deemed necessary to enhance the knowledge and attitudes of HCWs for better patient outcomes.

WHAT IS ALREADY KNOWN ON THIS TOPICPain is an undertreated clinical symptom and health burden affecting both hospitalized and non-hospitalized patients. Although pain has been designated as the 5th vital sign to ensure pain assessment and management, many patients continue to have uncontrolled or inadequate management of pain (1)(2). This negatively impacts the patients quality of life and overall wellbeing (2). A lack of adequate knowledge among HCWs remains a significant barrier to effective pain management (12), with misconceptions about pain evaluation; incorrect beliefs that patients overstate their pain; fears about drug tolerance and addiction; a lack of understanding of analgesic pharmacology; and difficulties in assessing pain in children (13).

WHAT THIS STUDY ADDSTo date, there are no published studies that assessed the knowledge and attitudes of physicians, nurses, and pharmacists toward pain management in Lebanon. Conducting such research is essential to identify discipline-specific gaps and inform strategies to improve pain management knowledge and clinical practice among physicians, nurses, and pharmacists alike.
]]></description>
<dc:creator><![CDATA[ Kassem, M., Bakri, C., Zeinab, N., Hindi, N., Samra, S. A., Jalabi, Z., Hammoud, A. ]]></dc:creator>
<dc:date>2025-11-01</dc:date>
<dc:identifier>doi:10.1101/2025.10.28.25336335</dc:identifier>
<dc:title><![CDATA[Healthcare Worker s (HCWs) Knowledge and Attitudes Related to Pain Management in a Lebanese Tertiary Hospital]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2025-11-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.22.26358710v1?rss=1">
<title>
<![CDATA[
Assessing Pain Catastrophizing Through Free-Text Responses: A Validation of Large Language Models 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.22.26358710v1?rss=1
</link>
<description><![CDATA[
Validated measures of pain catastrophizing primarily assess catastrophizing as a stable trait. However, emerging evidence suggests catastrophizing fluctuates with context, highlighting a need for ecologically valid methods to capture it. This study evaluated large language models (LLMs) as implicit markers of catastrophizing from free-text responses from ninety-one adults with chronic pain receiving long-term opioid therapy (57.3% Female; mean age = 60.5 years). Patients completed baseline measures, including the trait pain catastrophizing scale (PCS), followed by a 10-minute writing task after random assignment to a negative, positive, or neutral pain-coping condition. State affect and pain were assessed before and after writing tasks and again after a cold pressor task (4{o}C; [&le;] 2 minutes). A state PCS followed the cold pressor task. Free-text responses were analyzed using four LLMs (Claude Opus 4; GPT Mini 4o; Llama 4 Maverick; and Gemini 2.5 Pro). ANOVA-based results supported discriminant validity, as all four LLM-derived pain catastrophizing scores differentiated negative from positive and neutral pain-coping conditions. Convergent validity was model-dependent; only Gemini-derived scores correlated with state catastrophizing (r = .22) and pain unpleasantness (r = .23). Divergent validity was mixed. LLM-derived scores were unrelated to pain intensity, but Gemini and Claude-derived scores showed small correlations with trait PCS (rs = .21; 28, respectively). All LLM-derived scores also correlated with negative affect (rs = .29-.41), comparable in magnitude to state PCS, suggesting limited specificity. These findings provide preliminary evidence that certain LLMs may serve as implicit markers of state pain catastrophizing, but further study is needed.

SummaryLeading Large Language Models (LLMs) demonstrate discriminant validity but mixed convergent and divergent validity scoring pain catastrophizing from persons living with chronic pain free-text responses.
]]></description>
<dc:creator><![CDATA[ Lee, A., You, D. S., Dildine, T. C. ]]></dc:creator>
<dc:date>2026-07-27</dc:date>
<dc:identifier>doi:10.64898/2026.07.22.26358710</dc:identifier>
<dc:title><![CDATA[Assessing Pain Catastrophizing Through Free-Text Responses: A Validation of Large Language Models]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.24.26358500v1?rss=1">
<title>
<![CDATA[
Development and Psychometric Validation of the Pelvic Dystonia Severity Scale (PDSS) 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.24.26358500v1?rss=1
</link>
<description><![CDATA[
BackgroundChronic pelvic pain with involuntary pelvic-floor hypertonicity is common, disabling, and inconsistently measured, and no validated condition-specific severity instrument exists. A refractory subset has been proposed to represent a focal dystonia of the pelvic musculature, termed pelvic dystonia.

PurposeTo develop the Pelvic Dystonia Severity Scale (PDSS) and evaluate its measurement properties as a patient-reported measure of pelvic-pain symptom severity and burden, following the COSMIN guidelines.

MethodsCross-sectional study with a test-retest component in 102 adults from an outpatient multidisciplinary pain practice. We assessed data quality, structural validity, internal consistency, test-retest reliability, measurement error, and construct validity against the Global Dystonia Severity Rating Scale (GDS) and Brief Pain Inventory (BPI). Because no validated diagnostic criteria exist, a clinician blinded to PDSS responses rated each participant for clinical signs of pelvic dystonia (present/possible/absent) as a provisional reference standard.

Results100 of 102 participants (98%) returned complete data, with 0% item-level missing data. Factor analysis supported a unidimensional structure (single factor, 68.6% of variance; loadings 0.56-0.93), with high subscale intercorrelations (r = 0.81-0.97). Internal consistency (Cronbachs  0.810-0.924) and test-retest reliability (ICC 0.857-0.953) were strong. Convergent validity was supported by correlations with GDS pelvic-region items (r = 0.56-0.68) and BPI severity (r = 0.44-0.55), and discriminant validity by weak correlations with anatomically remote regions (shoulder/arm r = 0.03-0.16). PDSS scores rose monotonically across blinded clinical-signs categories (absent 14.9, possible 32.7, present 52.0; Kruskal-Wallis p < 0.001), discriminating signs-present from signs-absent participants with a very large effect (Hedges g = 2.19; ROC AUC = 0.92).

ConclusionThe PDSS is a psychometrically robust, unidimensional measure of pelvic-pain symptom severity and burden with strong data quality, reliability, and construct validity. It is suitable for characterizing symptom severity and, pending responsiveness testing, for monitoring treatment. The dystonia interpretation of the underlying phenotype is discussed as a hypothesis for future neurophysiologic and longitudinal study.
]]></description>
<dc:creator><![CDATA[ Siefferman, J., Safroshkina, M., Nazarova, I., Zaznaev, A., Hasan, S. ]]></dc:creator>
<dc:date>2026-07-29</dc:date>
<dc:identifier>doi:10.64898/2026.07.24.26358500</dc:identifier>
<dc:title><![CDATA[Development and Psychometric Validation of the Pelvic Dystonia Severity Scale (PDSS)]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.31.26359372v1?rss=1">
<title>
<![CDATA[
Pain-Reporting Variability and Reliability as Predictors of Placebo Effects: A Cross-Sectional Experimental Pain Study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.31.26359372v1?rss=1
</link>
<description><![CDATA[
Placebo analgesia varies substantially across individuals, yet the sources of this heterogeneity remain incompletely understood. Pain-reporting variability may represent an underrecognized predictor of placebo responsiveness. This study examined whether variability and reliability of pain reporting predict placebo analgesia in an experimental pain setting.

Eight hundred and three participants (401 individuals with temporomandibular disorder and 400 healthy controls) completed a standardized thermal pain paradigm involving calibration, placebo conditioning, and testing phases. We obtained repeated heat temperatures (four) during thermal calibration and pain ratings during conditioning test (24 trials). We used these measurements to quantify within-person pain-reporting variability using standard deviation (SD) and coefficient of variation (CoV), and reliability using intraclass correlation coefficients (ICC). Placebo analgesia was calculated as the difference in pain ratings between control and placebo cue trials during testing. Regression models examined associations between reporter characteristics and placebo analgesia controlling for age, sex, race and experimenters.

Variability of thermal pain responses during calibration did not predict placebo analgesia. Greater pain-reporting variability during conditioning was associated with reduced placebo analgesia (higher SD and CoV), and this effect was mediated by slower acquisition of the cue- pain contingency. Conditioning-phase reliability was not associated with placebo analgesia, whereas three clusters of learning profiles predicted placebo effects. Thus, individual differences in pain-reporting variability during conditioning, rather than baseline sensory variability, contribute to heterogeneity in placebo analgesia. These findings suggest that variability during acquisition processing matters more than general sensory variability influencing the magnitude of placebo effects.
]]></description>
<dc:creator><![CDATA[ Cottam, J. A., Wang, Y., Akintola, T., Farrar, J., Chen, C., McArdle, P., Ament, S. A., Corlett, P., Dorsey, S. G., Treister, R., Colloca, L. ]]></dc:creator>
<dc:date>2026-08-05</dc:date>
<dc:identifier>doi:10.64898/2026.07.31.26359372</dc:identifier>
<dc:title><![CDATA[Pain-Reporting Variability and Reliability as Predictors of Placebo Effects: A Cross-Sectional Experimental Pain Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-08-05</prism:publicationDate>
<prism:section></prism:section>
</item>
</rdf:RDF>
